Suppr超能文献

耐碳青霉烯类药物的胃肠道定植:对感染控制有何影响?

Gastrointestinal Colonization of Carbapenem-Resistant : What Is the Implication for Infection Control?

作者信息

Wong Shuk-Ching, Chen Jonathan Hon-Kwan, Chau Pui-Hing, So Simon Yung-Chun, AuYeung Christine Ho-Yan, Yuen Lithia Lai-Ha, Chan Veronica Wing-Man, Lam Germaine Kit-Ming, Chiu Kelvin Hei-Yeung, Ho Pak-Leung, Lo Janice Yee-Chi, Yuen Kwok-Yung, Cheng Vincent Chi-Chung

机构信息

Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong SAR, China.

Department of Microbiology, Queen Mary Hospital, Hong Kong SAR, China.

出版信息

Antibiotics (Basel). 2022 Sep 22;11(10):1297. doi: 10.3390/antibiotics11101297.

Abstract

The epidemiology of patients with gastrointestinal colonization of carbapenem-resistant Acinetobacter baumannii (CRAB) has not been systematically analyzed. We aimed to analyze the incidence, risk factors, and clinical outcomes of patients with newly identified gastrointestinal colonization of CRAB in a healthcare region in Hong Kong, where a multi-pronged screening strategy for gastrointestinal colonization of CRAB, together with other multidrug-resistant organisms (MDROs), was conducted by collecting fecal specimens (rectal swab or stool) upon admission and during hospitalization. From 1 October 2015 to 31 December 2019, a total of 161,339 fecal specimens from 63,588 patients, 61,856 (97.3%) of whom were hospitalized patients, and 54,525 (88.1%) were screened upon admission, with 1309 positive for CRAB (2.4% prevalence). Among patients positive for CRAB in fecal specimens, 698 (53.3%) had newly detected gastrointestinal colonization of CRAB, giving an incidence of 10.03 per 10,000 patient admissions and constituting 2646 CRAB colonization days in the general wards. Excluding the 164 patients with co-colonization of other MDROs, 534 patients had gastrointestinal colonization with only CRAB, and 12.5% (67/534) developed symptomatic CRAB infections at a median of 61 days (range: 2 to 671 days), during prospective follow-up for 2 years. Compared with age- and sex-matched controls, patients being referred from residential care homes for the elderly, the presence of indwelling devices, use of beta-lactam/beta-lactamase inhibitors, carbapenems, and proton pump inhibitors in the preceding 6 months, and history of hospitalization in the past 6 months were significantly associated with gastrointestinal colonization with CRAB, as shown by multivariable analysis. Log-rank test showed that cases had significantly shorter survival duration than controls (p < 0.001). The adjusted hazard ratio of gastrointestinal colonization of CRAB was 1.8 (95% CI: 1.5−2.2; p < 0.001), as shown by Cox regression analysis. Whole-genome sequencing of eight patients with CRAB isolates in their blood cultures and rectal swabs during the same episode of hospitalization revealed ST-195 as the predominant type, as shown by multilocus sequencing type. Gastrointestinal colonization of CRAB poses a considerable challenge for infection prevention and control.

摘要

耐碳青霉烯鲍曼不动杆菌(CRAB)胃肠道定植患者的流行病学尚未得到系统分析。我们旨在分析香港某医疗区域新发现的CRAB胃肠道定植患者的发病率、危险因素和临床结局,该区域通过在入院时和住院期间收集粪便标本(直肠拭子或粪便),对CRAB以及其他多重耐药菌(MDROs)的胃肠道定植采取了多管齐下的筛查策略。2015年10月1日至2019年12月31日,共收集了63588例患者的161339份粪便标本,其中61856例(97.3%)为住院患者,54525例(88.1%)在入院时接受了筛查,CRAB阳性1309例(患病率2.4%)。在粪便标本CRAB阳性的患者中,698例(53.3%)为新检测到的CRAB胃肠道定植,每10000例患者入院的发病率为10.03,在普通病房构成2646个CRAB定植日。排除164例合并其他MDROs定植的患者后,534例患者仅胃肠道定植CRAB,在2年的前瞻性随访期间,12.5%(67/534)的患者在中位时间61天(范围:2至671天)出现有症状的CRAB感染。多变量分析显示,与年龄和性别匹配的对照组相比,来自老年护理院的转诊患者、存在留置装置、在过去6个月内使用β-内酰胺/β-内酰胺酶抑制剂、碳青霉烯类和质子泵抑制剂以及过去6个月内的住院史与CRAB胃肠道定植显著相关。对数秩检验显示,病例的生存时间明显短于对照组(p<0.001)。Cox回归分析显示,CRAB胃肠道定植的调整后风险比为1.8(95%CI:1.5−2.2;p<0.001)。多位点测序分型显示,在同一住院期间血培养和直肠拭子中分离出CRAB的8例患者的全基因组测序显示,ST-195为主要类型。CRAB的胃肠道定植对感染预防和控制构成了相当大的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/202e/9598245/f5d54c272258/antibiotics-11-01297-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验